Ki-67 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ki-67" in Japanese language version.

refsWebsite

Global rank Japanese rank

15nih.gov

4^th place

24^th place

12doi.org

2^nd place

6^th place

1cell.com

2,814^th place

4,178^th place

1nature.com

234^th place

363^rd place

cell.com

http://www.cell.com/trends/cell-biology/pdf/S0962-8924(17)30136-8.pdf

doi.org

“Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10”. Hum. Genet. 83 (3): 297–9. (October 1989). doi:10.1007/BF00285178. PMID 2571566.
“Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells”. J. Cell. Physiol. 206 (3): 624–35. (March 2006). doi:10.1002/jcp.20494. PMID 16206250.
“Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis”. Cell Prolif. 40 (3): 422–30. (June 2007). doi:10.1111/j.1365-2184.2007.00433.x. PMID 17531085.
“The Ki-67 protein: from the known and the unknown”. Journal of Cellular Physiology 182 (3): 311–22. (March 2000). doi:10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9. PMID 10653597.
“Ki-67 acts as a biological surfactant to disperse mitotic chromosomes”. Nature 535 (7611): 308-12. (July 2016). doi:10.1038/nature18610. PMC 4947524. PMID 27362226.
“Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells”. Cell Proliferation 25 (1): 31–40. (January 1992). doi:10.1111/j.1365-2184.1992.tb01435.x. PMID 1540682.
“Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry”. Oncotarget 6 (14): 11735–50. (May 2015). doi:10.18632/oncotarget.4149. PMC 4494901. PMID 26059433.
“Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer”. European Journal of Cancer (Oxford, England : 1990) 51 (12): 1481–9. (2015). doi:10.1016/j.ejca.2015.03.018. PMID 26074397.
“Ki67 in breast cancer: prognostic and predictive potential”. The Lancet. Oncology 11 (2): 174–83. (2010). doi:10.1016/S1470-2045(09)70262-1. PMID 20152769.
Bánkfalvi A (November 2000). “Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use.”. Histopathology 37 (5): 411–9. doi:10.1046/j.1365-2559.2000.00984.x. PMID 11119122.
“Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation”. Int. J. Cancer 31 (1): 13–20. (1983). doi:10.1002/ijc.2910310104. PMID 6339421.
“Interaction of the chromatin compaction-inducing domain (LR domain) of Ki-67 antigen with HP1 proteins”. Genes to Cells : Devoted to Molecular & Cellular Mechanisms 7 (12): 1231–42. (2002). doi:10.1046/j.1365-2443.2002.00596.x. PMID 12485163.

nature.com

https://www.nature.com/articles/nature18610

nih.gov

pubmed.ncbi.nlm.nih.gov

“Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10”. Hum. Genet. 83 (3): 297–9. (October 1989). doi:10.1007/BF00285178. PMID 2571566.
“Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells”. J. Cell. Physiol. 206 (3): 624–35. (March 2006). doi:10.1002/jcp.20494. PMID 16206250.
“Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis”. Cell Prolif. 40 (3): 422–30. (June 2007). doi:10.1111/j.1365-2184.2007.00433.x. PMID 17531085.
“The Ki-67 protein: from the known and the unknown”. Journal of Cellular Physiology 182 (3): 311–22. (March 2000). doi:10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9. PMID 10653597.
“Ki-67 acts as a biological surfactant to disperse mitotic chromosomes”. Nature 535 (7611): 308-12. (July 2016). doi:10.1038/nature18610. PMC 4947524. PMID 27362226.
“Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells”. Cell Proliferation 25 (1): 31–40. (January 1992). doi:10.1111/j.1365-2184.1992.tb01435.x. PMID 1540682.
“Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry”. Oncotarget 6 (14): 11735–50. (May 2015). doi:10.18632/oncotarget.4149. PMC 4494901. PMID 26059433.
“Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer”. European Journal of Cancer (Oxford, England : 1990) 51 (12): 1481–9. (2015). doi:10.1016/j.ejca.2015.03.018. PMID 26074397.
“Ki67 in breast cancer: prognostic and predictive potential”. The Lancet. Oncology 11 (2): 174–83. (2010). doi:10.1016/S1470-2045(09)70262-1. PMID 20152769.
Bánkfalvi A (November 2000). “Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use.”. Histopathology 37 (5): 411–9. doi:10.1046/j.1365-2559.2000.00984.x. PMID 11119122.
“Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation”. Int. J. Cancer 31 (1): 13–20. (1983). doi:10.1002/ijc.2910310104. PMID 6339421.
“Interaction of the chromatin compaction-inducing domain (LR domain) of Ki-67 antigen with HP1 proteins”. Genes to Cells : Devoted to Molecular & Cellular Mechanisms 7 (12): 1231–42. (2002). doi:10.1046/j.1365-2443.2002.00596.x. PMID 12485163.